mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

Mostrar otras versiones (1)

Recent surveillance has revealed the emergence of the SARS-CoV-2 Omicron variant (BA.1/B.1.1.529) harboring up to 36 mutations in spike protein, the target of neutralizing antibodies. Given its potential to escape vaccine-induced humoral immunity, we measured the neutralization potency of sera from...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Beltran, Wilfredo F., St. Denis, Kerri J., Hoelzemer, Angelique, Lam, Evan C., Nitido, Adam D., Sheehan, Maegan L., Berrios, Cristhian, Ofoman, Onosereme, Chang, Christina C., Hauser, Blake M., Feldman, Jared, Roederer, Alex L., Gregory, David J., Poznansky, Mark C., Schmidt, Aaron G., Iafrate, A. John, Naranbhai, Vivek, Balazs, Alejandro B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733787/
https://www.ncbi.nlm.nih.gov/pubmed/34995482
http://dx.doi.org/10.1016/j.cell.2021.12.033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733787/
https://www.ncbi.nlm.nih.gov/pubmed/34995482
http://dx.doi.org/10.1016/j.cell.2021.12.033

Ejemplares similares